| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/13/2003 | WO2002053741A8 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/13/2003 | WO2002053723B1 Degradation and detection of tse infectivity |
| 02/13/2003 | WO2002051434A3 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 02/13/2003 | WO2002047719A3 Survical promoting ncam binding and ncam ligand biding compounds |
| 02/13/2003 | WO2002046466A3 Complexes of brca and stat polypeptides and methods of use in the detection and treatment of cancer |
| 02/13/2003 | WO2002046378A3 Alternative pol k nucleotide and amino acid sequence and methods for using |
| 02/13/2003 | WO2002044357A3 Methods of using 18903 to treat pain and pain-related disorders |
| 02/13/2003 | WO2002042118A3 Oil maintenance indicator |
| 02/13/2003 | WO2002038805A3 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 02/13/2003 | WO2002038141A9 Compositions and methods for treatment of mild cognitive impairment |
| 02/13/2003 | WO2002038129A3 Delayed-release pharmaceutical formulations containing proinsulin c-peptide |
| 02/13/2003 | WO2002034283A3 Vegh inhibitors and their use |
| 02/13/2003 | WO2002033114A3 Protein-protein interactions in neurodegenerative diseases |
| 02/13/2003 | WO2002032958A3 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
| 02/13/2003 | WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation |
| 02/13/2003 | WO2002029105A9 INHIBITION OF TGF-β AND USES THEREOF |
| 02/13/2003 | WO2002026778A3 Isolated peptides which bind to hla-c molecules and uses thereof |
| 02/13/2003 | WO2002026325A9 Restoration of perturbed barrier function by application of antiandrogens |
| 02/13/2003 | WO2002018565A3 Regulation of human protein phosphatase iic-like enzyme |
| 02/13/2003 | WO2002009755A3 Apo-2l receptor agonist and cpt-11 synergism |
| 02/13/2003 | WO2002007758A3 Method for induced lactation |
| 02/13/2003 | WO2002007753A3 Method for treating unstable angina pectoris |
| 02/13/2003 | WO2002006515A3 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 02/13/2003 | WO2002004613A3 Isolated polynucleotides encoding human 5'-nucleotide cn-ia and cn-ib, isolated proteins encoded by the same, and methods utilizing the same |
| 02/13/2003 | WO2002000862A8 32447, a novel human acyltransferase and uses thereof |
| 02/13/2003 | WO2002000702A3 Regulation of human epidermis-specific serine protease |
| 02/13/2003 | WO2001092567A3 Novel target genes for diseases of the heart |
| 02/13/2003 | WO2001092331A8 Compositions and methods for the treatment of immune related diseases |
| 02/13/2003 | WO2001087286A3 Antisense enzyme inhibitors for improving pharmacokinetics of a drug |
| 02/13/2003 | WO2001070772A3 Molecule of pharmaceutical interest comprising at its n-terminal a glutamic acid or a glutamine in the form of an addition salt to an acid |
| 02/13/2003 | WO2001060398A8 Drugs for ameliorating impaired glucose tolerance |
| 02/13/2003 | WO2001057277A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human fetal liver |
| 02/13/2003 | WO2001057270A3 Human genome-derived single exon nucleic acid probes useful for analysis of gene expression in human breast and hbl 100 cells |
| 02/13/2003 | US20030033617 Generation of nuclear transfer embryo; obtain cells, remove nucleus from one, transfer to enucleated cell, transform with artifical chromosome, recover and monitor gene expresion in the cell |
| 02/13/2003 | US20030033088 Method of generating chemical compounds having desired properties |
| 02/13/2003 | US20030032945 Coated filter bag material for oral administration of medicament in liquid and methods of making same |
| 02/13/2003 | US20030032790 Mammal use as model in the diagnosis, prevention and treatment of hypercholesteremia or hyperlipoproteinemia, obesity, diabetes, tumors, anorexia, hyperlipidemia, lipoprotein defects, osteoporosis, arthritis and tumors |
| 02/13/2003 | US20030032788 Oligonucleotide sequences for use in the prevention and for controlling the consumption of alcoholic beverages |
| 02/13/2003 | US20030032786 Polynucleotide encoding a novel human potassium channel beta-subunit, K+betaM2 |
| 02/13/2003 | US20030032784 Novel G protein-coupled receptors |
| 02/13/2003 | US20030032783 Nucleotide sequences coding polypeptide for use in the treatment of hyperlipidemia, diabetes, brain, arteriosclerosis, and cardiovascular disorders |
| 02/13/2003 | US20030032781 Antibody for use in the treatment of cancer |
| 02/13/2003 | US20030032780 Process for inactivating pionts in lipoproteins |
| 02/13/2003 | US20030032776 Polynucleotide encoding a novel human potassium channel beta-subunit, K+Mbeta1 |
| 02/13/2003 | US20030032775 Effector proteins of rapamycin |
| 02/13/2003 | US20030032774 Novel opioid peptides for the treatment of pain |
| 02/13/2003 | US20030032773 Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (BAD) and unipolar depression |
| 02/13/2003 | US20030032772 Peptide for use in the diagnosis and prevention of immunological and infectious disorders |
| 02/13/2003 | US20030032771 Peptide inhibitors of cellular proliferation |
| 02/13/2003 | US20030032769 Second mammalian tankyrase |
| 02/13/2003 | US20030032651 Intrathecal analgesia method |
| 02/13/2003 | US20030032618 Pharmaceutical combinations |
| 02/13/2003 | US20030032612 Inhibit expression of a gene in the operon; reducing bacterial resistance to antibiotics |
| 02/13/2003 | US20030032610 Administering one or more oligonucleotides which share at least 50% nucleotide sequence identity with (TTAGGG)n or oligonucleotides which share at least 50% nucleotide sequence identity with the human telomere overhang repeat. |
| 02/13/2003 | US20030032609 Promoting agniogenesis with a compound that increases expression of VEGF; inhibiting angiogenesis with a compound that inhibits binding of endothelial PAS domain protein-1 to cis-acting transcription regulatory DNA an angiogenic factor. |
| 02/13/2003 | US20030032607 Oligonucleotides targeted to nucleic acids encoding human raf and capable of inhibiting raf expression; may have chemical modifications at one or more positions and may be chimeric; inhibiting hyperproliferation of cells |
| 02/13/2003 | US20030032601 Method for isolating sponge collagen and producing nanoparticulate collagen, and the use thereof |
| 02/13/2003 | US20030032599 Inhibiting growth or survival of a microorganism, comprising directly contacting the microorganism with a substance P peptide or a peptide mimetic thereof. |
| 02/13/2003 | US20030032598 Method to treat pulmonary hypoplasia in the newborn |
| 02/13/2003 | US20030032596 Administering a compound that modulates the synthesis or expression of a target cellular gene, especially a Src kinase. |
| 02/13/2003 | US20030032595 Compositions and methods relating to glucose metabolism, weight control, and food intake |
| 02/13/2003 | US20030032594 Intracellular delivery of biological effectors |
| 02/13/2003 | US20030032593 Transporters comprising spaced arginine moieties |
| 02/13/2003 | US20030032591 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 02/13/2003 | US20030032590 Method of treating anemia caused by ribavirin treatment of hepatitis C using erythropoietin alpha |
| 02/13/2003 | US20030032589 NGF for the prevention of demyelination in the nervous system |
| 02/13/2003 | US20030032588 Glucagon antagonists |
| 02/13/2003 | US20030032587 Urocortin peptides |
| 02/13/2003 | US20030032586 Compositions for morphogen-induced osteogenesis |
| 02/13/2003 | US20030032585 The use of trefoil factor 2 (TFF2) peptides increasing the viscosity of mucus layers in mammals |
| 02/13/2003 | US20030032584 Inhibiting abnormal cellular proliferation in a mammal; and a method of inhibiting replication of a virus in a mammal. |
| 02/13/2003 | US20030032583 Stabilizing a glutamine-rich nutritional composition comprising the steps of providing a composition comprising a wheat protein hydrolysate, and adding caseinate in said composition. |
| 02/13/2003 | US20030032582 Spontaneous membrane insertion |
| 02/13/2003 | US20030032200 Proteins, genes and their use for diagnosis and treatment of bipolar affective disorder (BAD) and unipolar depression |
| 02/13/2003 | US20030032168 Human ADAMTS-1 protein, gene encoding the same, pharmaceutical composition, and method for immunologically analyzing human ADAMTS-1 protein |
| 02/13/2003 | US20030032166 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 02/13/2003 | US20030032159 Human ralgds-like protein 3 |
| 02/13/2003 | US20030032158 Method of modulating the efficiency of translation termination and degradation of aberrant mRNA involving a surveillance complex comprising human Upf1p,eucaryotic release factor 1 and eucaryotic release factor 3 |
| 02/13/2003 | US20030032156 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 02/13/2003 | US20030032155 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032154 Human LCCL domain containing protein |
| 02/13/2003 | US20030032145 Pharmaceutical compositions including variants of vascular endothelial cell growth factor having altered pharmacological properties |
| 02/13/2003 | US20030032144 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 02/13/2003 | US20030032143 Collagen type I and type III compositions for use as an adhesive and sealant |
| 02/13/2003 | US20030032142 Nucleotide sequences coding membrane protein for use in the treatment and prevention of infections |
| 02/13/2003 | US20030032098 Bone morphogenic protein |
| 02/13/2003 | US20030032097 DNA encoding human vanilloid receptor VR3 |
| 02/13/2003 | US20030032096 Parathyroid hormone receptor ligands |
| 02/13/2003 | US20030032095 Novel nucleic acid sequences encoding human semaphorin-like polypeptides |
| 02/13/2003 | US20030032090 Human receptor proteins; related reagents and methods |
| 02/13/2003 | US20030032089 Isolated cocoon silk protein from simulium vittatum and nucleic acids encoding such protein |
| 02/13/2003 | US20030032087 121P1F1: a tissue specific protein highly expressed in various cancers |
| 02/13/2003 | US20030032075 Monoclonal or recombinant antibody for use in the treatment of tumors |
| 02/13/2003 | US20030032073 Method for diagnosis and therapy of Hodgkin's lymphomas |
| 02/13/2003 | US20030032065 Ensemble-based strategy for the design of protein pharmaceuticals |
| 02/13/2003 | US20030032063 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032062 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032061 Nucleotide sequences coding polypeptide for use in the treatment of inflammation, tumors and immunological and inflammatory bowel disease |
| 02/13/2003 | US20030032058 Protein-protein interactions |
| 02/13/2003 | US20030032057 Secreted and transmembrane polypeptides and nucleic acids encoding the same |